PortfoliosLab logoPortfoliosLab logo
apr 26 rebal 1
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


GDX 22.19%SIVR 5.51%1 position 2.15%RDIV 48.97%VOO 10.28%18 positions 7.66%1 position 3.09%AlternativesAlternativesCommodityCommodityEquityEquityMulti-AssetMulti-Asset
PositionCategory/SectorTarget Weight
RDIV
Invesco S&P Ultra Dividend Revenue ETF
Mid Cap Value Equities, Dividend
48.97%
GDX
VanEck Gold Miners ETF
Gold, Precious Metals
22.19%
VOO
Vanguard S&P 500 ETF
S&P 500
10.28%
SIVR
abrdn Physical Silver Shares ETF
Silver, Precious Metals
5.51%
RAAX
VanEck Inflation Allocation ETF
Diversified Portfolio
3.09%
PPH
VanEck Pharmaceutical ETF
Health & Biotech Equities
2.54%
OUNZ
VanEck Merk Gold Trust
Precious Metals, Gold
2.15%
MLI
Mueller Industries, Inc.
Industrials
0.88%
SCHG
Schwab U.S. Large-Cap Growth ETF
Large Cap Growth Equities
0.73%
VXUS
Vanguard Total International Stock ETF
Global Equities
0.73%
ALKS
Alkermes plc
Healthcare
0.52%
PBE
Invesco Dynamic Biotechnology & Genome ETF
Health & Biotech Equities
0.48%
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
Nasdaq-100, Derivative Income
0.44%
DFTX
Definium Therapeutics, Inc
Healthcare
0.25%
PBD
Invesco Global Clean Energy ETF
Alternative Energy Equities
0.22%
FRNW
Fidelity Clean Energy ETF
Alternative Energy Equities
0.21%
ICLN
iShares Global Clean Energy ETF
Alternative Energy Equities
0.21%
MRNY
YieldMax MRNA Option Income Strategy ETF
Derivative Income, Dividend
0.15%
MSTY
YieldMax™ MSTR Option Income Strategy ETF
Derivative Income
0.15%
PSIL
AdvisorShares Psychedelics ETF
Health & Biotech Equities
0.13%
ENVB
Enveric Biosciences Inc
Healthcare
0.07%
IBBQ
Invesco Nasdaq Biotechnology ETF
Health & Biotech Equities
0.04%
CMPS
COMPASS Pathways plc
Healthcare
0.03%
FMED
Fidelity Disruptive Medicine ETF
Health & Biotech Equities
0.02%
VYGR
Voyager Therapeutics, Inc.
Healthcare
0.01%

S&P 500 Index

Portfolio Optimizer

Find the right asset allocation for apr 26 rebal 1

Add portfolio to the optimizer to find optimal allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in apr 26 rebal 1, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.


Loading charts...

Returns By Period


Position1D1MYTD6M1Y3Y*5Y*10Y*
Benchmark
S&P 500 Index
1.65%1.97%10.35%10.82%26.39%19.66%12.33%13.81%
Portfolio
apr 26 rebal 1
0.82%2.02%9.98%10.65%41.38%
ALKS
Alkermes plc
0.18%18.36%58.54%57.47%48.71%11.28%12.07%0.70%
CMPS
COMPASS Pathways plc
-2.40%13.69%70.87%78.91%168.56%15.31%-20.57%
DFTX
Definium Therapeutics, Inc
-3.96%13.24%77.52%96.77%231.52%84.74%
ENVB
Enveric Biosciences Inc
-3.27%-34.22%-59.23%-72.39%-89.81%-87.52%-85.10%-74.86%
FMED
Fidelity Disruptive Medicine ETF
0.90%7.10%-4.75%-6.17%8.53%0.73%
FRNW
Fidelity Clean Energy ETF
0.40%-4.24%23.62%23.50%63.53%6.49%
GDX
VanEck Gold Miners ETF
6.55%-2.38%-0.58%1.22%57.71%41.18%19.97%13.81%
IBBQ
Invesco Nasdaq Biotechnology ETF
0.54%2.51%4.83%4.79%40.36%13.02%4.49%
ICLN
iShares Global Clean Energy ETF
0.80%-3.23%28.34%28.17%61.48%5.46%-0.17%11.52%
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
2.21%3.31%10.23%11.56%29.39%20.72%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Feb 22, 2024, apr 26 rebal 1's average daily return is +0.12%, while the average monthly return is +2.42%. At this rate, an investment would double in approximately 2.4 years.

Historically, 76% of months were positive and 24% were negative. The best month was Aug 2025 with a return of +10.0%, while the worst month was Mar 2026 at -7.6%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 1 months.

On a daily basis, apr 26 rebal 1 closed higher 59% of trading days. The best single day was Apr 9, 2025 with a return of +7.1%, while the worst single day was Apr 4, 2025 at -6.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20266.60%8.00%-7.56%2.07%2.50%-1.22%9.98%
20255.76%1.53%2.55%-1.96%3.14%3.26%0.80%9.99%7.75%-0.59%6.02%2.14%47.85%
20240.52%9.08%-1.44%5.98%-1.90%7.33%2.45%1.85%0.54%1.82%-6.71%20.17%

Benchmark Metrics

apr 26 rebal 1 has an annualized alpha of 18.38%, beta of 0.71, and R2 of 0.43 versus S&P 500 Index. Calculated based on daily prices since February 22, 2024.

  • This portfolio captured 115.67% of S&P 500 Index gains but only 25.09% of its losses - a favorable profile for investors.
  • R2 of 0.43 means the benchmark explains less than half of this portfolio's behavior - treat beta with caution or consider switching to a more representative benchmark.

Alpha
18.38%
Beta
0.71
0.43
Upside Capture
115.67%
Downside Capture
25.09%

Expense Ratio

apr 26 rebal 1 has an expense ratio of 0.38%, placing it in the medium range. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


Top 10 holdings

Return for Risk

Risk / Return Rank

apr 26 rebal 1 ranks 57 for risk / return — on par with similar Portfolios. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


apr 26 rebal 1 Risk / Return Rank: 5757
Overall Rank
apr 26 rebal 1 Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
apr 26 rebal 1 Sortino Ratio Rank: 4949
Sortino Ratio Rank
apr 26 rebal 1 Omega Ratio Rank: 6161
Omega Ratio Rank
apr 26 rebal 1 Calmar Ratio Rank: 6565
Calmar Ratio Rank
apr 26 rebal 1 Martin Ratio Rank: 4444
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below presents risk-adjusted performance metrics for apr 26 rebal 1 and compares them with S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PortfolioBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

2.30

2.14

+0.16

Sortino ratioReturn per unit of downside risk

2.81

2.89

-0.08

Omega ratioGain probability vs. loss probability

1.40

1.39

+0.01

Calmar ratioReturn relative to maximum drawdown

3.34

2.91

+0.43

Martin ratioReturn relative to average drawdown

10.96

13.08

-2.12


How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

PositionRisk / Return RankSharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
ALKS
Alkermes plc
76
1.201.921.242.215.11
CMPS
COMPASS Pathways plc
85
1.642.361.363.329.89
DFTX
Definium Therapeutics, Inc
96
3.763.851.459.4029.57
ENVB
Enveric Biosciences Inc
11
-0.51-1.010.87-0.98-1.34
FMED
Fidelity Disruptive Medicine ETF
15
0.440.791.090.471.03
FRNW
Fidelity Clean Energy ETF
79
2.372.981.374.5015.55
GDX
VanEck Gold Miners ETF
35
1.231.651.231.604.39
IBBQ
Invesco Nasdaq Biotechnology ETF
74
2.022.851.334.8615.49
ICLN
iShares Global Clean Energy ETF
73
2.192.751.353.7713.82
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
81
2.313.061.463.3515.94

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk. Learn how to interpret the Sharpe ratio.

The current apr 26 rebal 1 Sharpe ratio is 2.30 as of Jun 13, 2026 (the value is recalculated daily), calculated over the past 12 months.

Compared to the broad market, where average Sharpe ratios range from 1.56 to 2.44, this portfolio's current Sharpe ratio falls between the 25th and 75th percentiles. This indicates that its risk-adjusted performance is in line with the majority of portfolios, suggesting a balanced approach to risk and return—likely suitable for a wide range of investors.

The chart below shows the rolling Sharpe ratio of apr 26 rebal 1 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading charts...

Dividends

Dividend yield

apr 26 rebal 1 provided a 2.73% dividend yield over the last twelve months.


PositionTTM20252024202320222021202020192018201720162015
Portfolio2.73%3.10%3.01%2.69%2.41%2.47%2.96%2.39%2.56%2.61%1.46%2.70%
ALKS
Alkermes plc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CMPS
COMPASS Pathways plc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
DFTX
Definium Therapeutics, Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ENVB
Enveric Biosciences Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FMED
Fidelity Disruptive Medicine ETF
0.00%0.00%0.46%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FRNW
Fidelity Clean Energy ETF
1.02%1.25%1.43%1.30%0.69%0.04%0.00%0.00%0.00%0.00%0.00%0.00%
GDX
VanEck Gold Miners ETF
0.74%0.74%1.19%1.61%1.66%1.67%0.53%0.67%0.50%0.76%0.26%0.85%
IBBQ
Invesco Nasdaq Biotechnology ETF
0.84%0.90%1.14%0.81%0.76%0.63%0.00%0.00%0.00%0.00%0.00%0.00%
ICLN
iShares Global Clean Energy ETF
1.54%1.63%1.85%1.59%0.89%1.18%0.34%1.36%2.77%2.49%3.88%2.36%
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
10.00%10.53%9.65%10.03%9.44%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the apr 26 rebal 1. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the apr 26 rebal 1 was 12.44%, occurring on Mar 20, 2026. The portfolio has not yet recovered.

The current apr 26 rebal 1 drawdown is 5.29%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 correction2026
-12.44%Mar 2026
17d
3mo 15dMar 2026 - now
2025 selloff2025
-11.95%Apr 2025
5d1mo 11d
1mo 16dApr 2025 - May 2025
2024 pullback2024
-8.67%Dec 2024
1mo 27d1mo 26d
3mo 23dOct 2024 - Feb 2025
2024 pullback2024
-6.37%Aug 2024
21d12d
1mo 3dJul 2024 - Aug 2024
2026 pullback2026
-6.29%Feb 2026
7d20d
27dJan 2026 - Feb 2026

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Diversification

Diversification Metrics


Number of Effective Assets

The portfolio contains 25 assets, with an effective number of assets of 3.28, reflecting the diversification based on asset allocation. Your portfolio is dominated by one or two holdings, which significantly increases concentration risk. Consider rebalancing toward more even weights or adding additional positions.


Diversification Ratio
1Y
All Time
Diversification Ratio

1.40

1.42

The portfolio has a diversification ratio of 1.42, in line with the typical range across portfolios. There's room to improve by adding less correlated assets.

apr 26 rebal 1 correlation to the S&P 500 Index

apr 26 rebal 1 has a 0.55 correlation to S&P 500 Index over the trailing 12 months. This section compares each holding's correlation to the benchmark and to the portfolio.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.55

Correlation (All Time)
Calculated using the full available price history since Feb 22, 2024

0.56


Benchmark Correlations

Correlation vs. S&P 500 Index. VOO has the highest benchmark correlation at 1.00, while OUNZ has the lowest at 0.16.

OUNZ
0.16
ENVB
0.21
SIVR
0.26
ALKS
0.26
GDX
0.28
DFTX
0.33
PPH
0.34
CMPS
0.35
RAAX
0.37
MRNY
0.37
PSIL
0.40
VYGR
0.41
MSTY
0.45
RDIV
0.47
ICLN
0.48
FRNW
0.53
MLI
0.54
PBE
0.54
IBBQ
0.55
FMED
0.62
PBD
0.63
VXUS
0.74
JEPQ
0.93
SCHG
0.94
VOO
1.00

Portfolio Correlations

Correlation vs. apr 26 rebal 1. GDX has the highest portfolio correlation at 0.81, while ENVB has the lowest at 0.20.

ENVB
0.20
DFTX
0.24
ALKS
0.25
CMPS
0.26
PSIL
0.31
MSTY
0.31
VYGR
0.31
MRNY
0.36
PPH
0.39
SCHG
0.41
JEPQ
0.45
FMED
0.47
MLI
0.47
PBE
0.49
ICLN
0.49
IBBQ
0.50
FRNW
0.51
VOO
0.56
PBD
0.56
RDIV
0.59
OUNZ
0.66
VXUS
0.69
SIVR
0.69
RAAX
0.72
GDX
0.81

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

ENVBOUNZALKSSIVRDFTXPPHMSTYCMPSGDXMRNYRDIVPSILVYGRMLIRAAXICLNFRNWSCHGPBEJEPQFMEDPBDIBBQVOOVXUS
ENVB1.000.030.130.070.180.130.130.150.070.210.210.270.180.150.130.170.210.180.210.170.260.220.200.210.17
OUNZ0.031.000.030.760.080.120.160.100.810.150.030.120.110.120.640.250.240.130.160.140.160.260.190.160.39
ALKS0.130.031.000.060.210.360.150.180.080.290.310.210.340.260.140.200.200.190.500.190.400.250.500.260.24
SIVR0.070.760.061.000.100.110.210.160.770.190.070.150.130.140.530.300.310.240.190.260.190.360.220.260.47
DFTX0.180.080.210.101.000.190.290.480.100.220.230.590.380.250.210.240.270.320.400.310.380.280.440.330.29
PPH0.130.120.360.110.191.000.060.180.160.320.400.240.310.240.190.230.230.210.610.210.530.260.640.340.41
MSTY0.130.160.150.210.290.061.000.270.220.230.220.290.320.280.250.300.370.470.290.450.330.420.310.450.38
CMPS0.150.100.180.160.480.180.271.000.140.300.220.580.410.190.170.260.300.330.360.310.400.360.460.350.34
GDX0.070.810.080.770.100.160.220.141.000.180.100.160.140.210.600.370.360.240.230.260.240.370.260.280.50
MRNY0.210.150.290.190.220.320.230.300.181.000.310.270.410.300.220.310.330.310.500.330.490.410.580.370.40
RDIV0.210.030.310.070.230.400.220.220.100.311.000.250.300.520.390.320.360.250.470.300.420.410.450.470.44
PSIL0.270.120.210.150.590.240.290.580.160.270.251.000.370.240.280.290.330.380.410.370.460.380.480.400.34
VYGR0.180.110.340.130.380.310.320.410.140.410.300.371.000.290.170.260.320.370.500.350.490.370.590.410.37
MLI0.150.120.260.140.250.240.280.190.210.300.520.240.291.000.360.320.380.420.420.450.420.430.390.530.48
RAAX0.130.640.140.530.210.190.250.170.600.220.390.280.170.361.000.390.420.250.270.320.260.430.290.370.49
ICLN0.170.250.200.300.240.230.300.260.370.310.320.290.260.320.391.000.920.410.360.460.350.800.400.480.61
FRNW0.210.240.200.310.270.230.370.300.360.330.360.330.320.380.420.921.000.470.370.510.400.870.420.530.66
SCHG0.180.130.190.240.320.210.470.330.240.310.250.380.370.420.250.410.471.000.450.940.570.560.460.940.64
PBE0.210.160.500.190.400.610.290.360.230.500.470.410.500.420.270.360.370.451.000.450.760.450.890.540.51
JEPQ0.170.140.190.260.310.210.450.310.260.330.300.370.350.450.320.460.510.940.451.000.550.600.460.930.69
FMED0.260.160.400.190.380.530.330.400.240.490.420.460.490.420.260.350.400.570.760.551.000.480.790.620.56
PBD0.220.260.250.360.280.260.420.360.370.410.410.380.370.430.430.800.870.560.450.600.481.000.490.630.76
IBBQ0.200.190.500.220.440.640.310.460.260.580.450.480.590.390.290.400.420.460.890.460.790.491.000.550.53
VOO0.210.160.260.260.330.340.450.350.280.370.470.400.410.530.370.480.530.940.540.930.620.630.551.000.74
VXUS0.170.390.240.470.290.410.380.340.500.400.440.340.370.480.490.610.660.640.510.690.560.760.530.741.00
The correlation results are calculated based on daily price changes starting from Feb 22, 2024
Diversification Analysis

Find what apr 26 rebal 1 is missing

See which holdings overlap, where apr 26 rebal 1 is concentrated, and which low-correlation assets could fill the gaps.

Analyze Diversification